Role Of Chromium Supplementation In Indians With Type 2 Diabetes Mellitus
| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 6+ Months |
| Number of Subjects | 93 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Average |
Supplementation of chromium to type II diabetics for 28 weeks noted a reduction in blood glucose relative to baseline and placebo, and the minor changes in HbA1c and insulin turned out to be significant due to an increase seen in placebo. Weight and blood pressure were not significantly different, nor were any parameter of lipid metabolism measured.
